Literature DB >> 3923293

Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.

G E Wesbey, R C Brasch, H I Goldberg, B L Engelstad, A A Moss.   

Abstract

Delineation of the gastrointestinal tract in magnetic resonance imaging (MRI) remains a problem. Ferric ammonium citrate is paramagnetic, producing a high MRI signal intensity by virtue of its spin-lattice (T1) relaxation rate enhancement properties. Water is diamagnetic, producing a low MRI signal intensity, especially with short TR and TE times. To compare efficacy for gastrointestinal contrast alteration, ferric ammonium citrate was administered to 18 patients and water was given to 10 patients. Spin-echo imaging at 0.35T was performed after administration of these agents. Ferric ammonium citrate produced high signal intensity within the esophagus, stomach, duodenum, and small intestine that aided in the differentiation of the gastrointestinal tract from adjacent tumors, vessels, and viscera. Delineation of the gut wall was superior using ferric ammonium citrate compared to that produced by water. Delineation of the margins of the pancreas, liver, and kidney from adjacent gastrointestinal tract was also better with ferric ammonium citrate. Optimal distinction between bowel and fat was better with water. Longer TE times (75 to 200 ms) may allow improved contrast between gut and intrabdominal fat using ferric ammonium citrate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923293     DOI: 10.1016/0730-725x(85)90009-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

Review 1.  Imaging of the small bowel in Crohn's disease: a review of old and new techniques.

Authors:  Simone Saibeni; Emanuele Rondonotti; Andrea Iozzelli; Luisa Spina; Gian-Eugenio Tontini; Flaminia Cavallaro; Camilla Ciscato; Roberto de Franchis; Francesco Sardanelli; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

2.  Gd-DTPA as an intestinal contrast agent for MR imaging of the lower abdomen: phase III clinical trial.

Authors:  L Vlahos; A Gouliamos; W Clauss; A Kalovidouris; A Athanasopoulou; A Petroulakis; A Hadjiioannou; C Papavasiliou
Journal:  Gastrointest Radiol       Date:  1992
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.